In contrast, another study has demonstrated that BRD4 also can bind the EBV genome at oriLyt sites, whereas BRD4 acts as a promoter of the EBV lytic cycle (23), suggesting that these BRD family members are key regulators of the EBV life cycle by serving as either activator or inhibitor at different viral infection stages. This evidence concerns the gene BRD4 and viral infectious disease.